Asciminib Demonstrates Superior Efficacy and Safety in Newly Diagnosed Chronic Myeloid Leukemia in the ASC4FIRST Trial.
Cortes JE, Hughes TP, Wang J, Kim DW, Kim DDH, Mayer J, Goh YT, le Coutre P, Etienne G, Kim I, Andorsky D, Bombaci F, Issa GC, Takahashi N, Kapoor S, Jinwal R, Malek K, McCulloch T, Yau L, Larson RA, Hochhaus A.
Cortes JE, et al. Among authors: kapoor s.
Blood. 2025 Dec 15:blood.2025029210. doi: 10.1182/blood.2025029210. Online ahead of print.
Blood. 2025.
PMID: 41397287